Subtyping of human cellular prion proteins and their differential solubility
暂无分享,去创建一个
[1] H. Karch,et al. Differential solubility of prions is associated in manifold phenotypes , 2009, Molecular and Cellular Neuroscience.
[2] Thomas Arnold,et al. The Use of Detergents to Purify Membrane Proteins , 2008, Current protocols in protein science.
[3] J. Hauw,et al. Regulating Factors of PrPres Glycosylation in Creutzfeldt-Jakob Disease - Implications for the Dissemination and the Diagnosis of Human Prion Strains , 2008, PloS one.
[4] J. Manson,et al. Host PrP Glycosylation: A Major Factor Determining the Outcome of Prion Infection , 2008, PLoS biology.
[5] H. Karch,et al. Regional and phenotype heterogeneity of cellular prion proteins in the human brain , 2007, The European journal of neuroscience.
[6] J. Grassi,et al. Immunoreactivity enhancement with chelators for increasing the detection sensitivity of human PrPSc by Western blotting , 2007, Neurochemistry International.
[7] J. McGeehan,et al. Insoluble Aggregates and Protease-resistant Conformers of Prion Protein in Uninfected Human Brains* , 2006, Journal of Biological Chemistry.
[8] R. Riek,et al. The stoichiometry of host PrPC glycoforms modulates the efficiency of PrPSc formation in vitro. , 2006, Biochemistry.
[9] J. Langeveld,et al. Immunopathology and Infectious Diseases Detection of Type 1 Prion Protein in Variant Creutzfeldt-Jakob Disease , 2005 .
[10] A. Aguzzi,et al. Coexistence of multiple PrPSc types in individuals with Creutzfeldt-Jakob disease , 2005, The Lancet Neurology.
[11] J. Collinge,et al. Regional heterogeneity of cellular prion protein isoforms in the mouse brain. , 2003, Brain : a journal of neurology.
[12] Detlev Riesner,et al. Biochemistry and structure of PrP(C) and PrP(Sc). , 2003, British medical bulletin.
[13] Pauline M Rudd,et al. Glycosylation and prion protein. , 2002, Current opinion in structural biology.
[14] I. Vorberg,et al. Molecular Basis of Scrapie Strain Glycoform Variation* , 2002, The Journal of Biological Chemistry.
[15] C. Soto,et al. Cyclic amplification of protein misfolding: application to prion-related disorders and beyond , 2002, Trends in Neurosciences.
[16] Tong Liu,et al. Heterogeneity of normal prion protein in two‐dimensional immunoblot: presence of various glycosylated and truncated forms , 2002, Journal of neurochemistry.
[17] J. Collinge,et al. Tissue distribution of protease resistant prion protein in variant Creutzfeldt-Jakob disease using a highly sensitive immunoblotting assay , 2001, The Lancet.
[18] D. Dormont,et al. New insight into abnormal prion protein using monoclonal antibodies. , 1999, Biochemical and biophysical research communications.
[19] S. Prusiner,et al. Glycosylation differences between the normal and pathogenic prion protein isoforms. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[20] V. Daggett,et al. PrPc glycoform heterogeneity as a function of brain region: implications for selective targeting of neurons by prion strains. , 1999, Journal of neuropathology and experimental neurology.
[21] R. Dwek,et al. Glycoproteins: glycan presentation and protein-fold stability. , 1999, Structure.
[22] Stanley B. Prusiner,et al. Nobel Lecture: Prions , 1998 .
[23] B. Ghetti,et al. Endogenous proteolytic cleavage of normal and disease-associated isoforms of the human prion protein in neural and non-neural tissues. , 1998, The American journal of pathology.
[24] B. Faucheux,et al. Cellular prion protein localization in rodent and primate brain , 1998, The European journal of neuroscience.
[25] M. Groschup,et al. Generation of Monoclonal Antibodies against Human Prion Proteins in PrP0/0 Mice , 1996, Molecular medicine.
[26] Andrew F. Hill,et al. Molecular analysis of prion strain variation and the aetiology of 'new variant' CJD , 1996, Nature.
[27] D. Teplow,et al. Truncated Forms of the Human Prion Protein in Normal Brain and in Prion Diseases (*) , 1995, The Journal of Biological Chemistry.
[28] R J Fletterick,et al. Conversion of alpha-helices into beta-sheets features in the formation of the scrapie prion proteins. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[29] B. Caughey. Scrapie associated PrP accumulation and its prevention: insights from cell culture. , 1993, British medical bulletin.
[30] K. Kato,et al. High levels of nervous system-specific proteins in cerebrospinal fluid in patients with early stage Creutzfeldt-Jakob disease. , 1992, Clinica chimica acta; international journal of clinical chemistry.
[31] S. Prusiner,et al. Prions and prion proteins 1 , 1991, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[32] S. Prusiner,et al. Acquisition of protease resistance by prion proteins in scrapie-infected cells does not require asparagine-linked glycosylation. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[33] S. Prusiner,et al. Identification of glycoinositol phospholipid linked and truncated forms of the scrapie prion protein. , 1990, Biochemistry.
[34] D. Schmechel,et al. Neuron specific enolase, a clinically useful marker for neurons and neuroendocrine cells. , 1987, Annual review of neuroscience.
[35] S. Prusiner,et al. Molecular properties, partial purification, and assay by incubation period measurements of the hamster scrapie agent. , 1980, Biochemistry.
[36] N. Tolbert,et al. A modification of the Lowry procedure to simplify protein determination in membrane and lipoprotein samples. , 1978, Analytical biochemistry.
[37] U. K. Laemmli,et al. Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 , 1970, Nature.